IL6 and plasma cell myeloma: Dexamethasone, in particular, inhibits secretion of inflammatory cytokines by bone marrow stromal cells, such as IL-6 required for the growth of multiple myeloma (MM) cells [30], suggesting that immunotherapy against IL-6 could be helpful as adjuvant to treat MM.